APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endocrine Therapy Drugs (ETDs)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Endocrine Therapy Drugs (ETDs) Market Analysis and Forecast 2026-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchEndocrine Therapy Drugs (ETDs) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Endocrine Therapy Drugs (ETDs) Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Endocrine Therapy Drugs (ETDs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endocrine Therapy Drugs (ETDs) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Endocrine Therapy Drugs (ETDs) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Endocrine Therapy Drugs (ETDs) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Endocrine Therapy Drugs (ETDs) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Endocrine Therapy Drugs (ETDs) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Endocrine Therapy Drugs (ETDs) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Endocrine Therapy Drugs (ETDs) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Endocrine Therapy Drugs (ETDs) include Sanofi, Pfizer, Bayer, AstraZeneca, Tonghua Dongbao Pharmaceutical, Novo Nordisk, MSD, Huadong Medicine and Generex Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Endocrine Therapy Drugs (ETDs), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Endocrine Therapy Drugs (ETDs), also provides the sales of main regions and countries. Of the upcoming market potential for Endocrine Therapy Drugs (ETDs), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Endocrine Therapy Drugs (ETDs) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Endocrine Therapy Drugs (ETDs) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Endocrine Therapy Drugs (ETDs) sales, projected growth trends, production technology, application and end-user industry.

Endocrine Therapy Drugs (ETDs) Segment by Company

Sanofi

Pfizer

Bayer

AstraZeneca

Tonghua Dongbao Pharmaceutical

Novo Nordisk

MSD

Huadong Medicine

Generex Biotechnology

Endocrine Therapy Drugs (ETDs) Segment by Type

Antidiabetic Drugs

Anti-osteoporosis Drugs

Contraceptive

Other

Endocrine Therapy Drugs (ETDs) Segment by Application

Diabetes Treatment

Osteoporosis Treatment

Contraception

Other

Endocrine Therapy Drugs (ETDs) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Therapy Drugs (ETDs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endocrine Therapy Drugs (ETDs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Therapy Drugs (ETDs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Endocrine Therapy Drugs (ETDs) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Endocrine Therapy Drugs (ETDs) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endocrine Therapy Drugs (ETDs) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Endocrine Therapy Drugs (ETDs) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Antidiabetic Drugs Major Manufacturers Table 3. Anti-osteoporosis Drugs Major Manufacturers Table 4. Contraceptive Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Endocrine Therapy Drugs (ETDs) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Diabetes Treatment Major Manufacturers Table 8. Osteoporosis Treatment Major Manufacturers Table 9. Contraception Major Manufacturers Table 10. Other Major Manufacturers Table 11. Endocrine Therapy Drugs (ETDs) Industry Trends Table 12. Endocrine Therapy Drugs (ETDs) Industry Drivers Table 13. Endocrine Therapy Drugs (ETDs) Industry Opportunities and Challenges Table 14. Endocrine Therapy Drugs (ETDs) Industry Restraints Table 15. Global Endocrine Therapy Drugs (ETDs) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Endocrine Therapy Drugs (ETDs) Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Endocrine Therapy Drugs (ETDs) Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2021-2026) Table 19. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2027-2032) Table 20. Global Endocrine Therapy Drugs (ETDs) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 21. Global Endocrine Therapy Drugs (ETDs) Sales by Region (2021-2026) & (Tons) Table 22. Global Endocrine Therapy Drugs (ETDs) Sales by Region (2027-2032) & (Tons) Table 23. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Region (2021-2026) Table 24. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Region (2027-2032) Table 25. Global Endocrine Therapy Drugs (ETDs) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Endocrine Therapy Drugs (ETDs) Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Manufacturers (2021-2026) Table 29. Global Endocrine Therapy Drugs (ETDs) Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 30. Global Endocrine Therapy Drugs (ETDs) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Endocrine Therapy Drugs (ETDs) Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Endocrine Therapy Drugs (ETDs) Manufacturers, Product Type & Application Table 33. Global Endocrine Therapy Drugs (ETDs) Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Endocrine Therapy Drugs (ETDs) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Endocrine Therapy Drugs (ETDs) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2021-2026) Table 40. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2027-2032) Table 41. Global Endocrine Therapy Drugs (ETDs) Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 42. Global Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 43. Global Endocrine Therapy Drugs (ETDs) Sales by Type (2027-2032) & (Tons) Table 44. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2021-2026) Table 45. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2027-2032) Table 46. Global Endocrine Therapy Drugs (ETDs) Price by Type (2021-2026) & (US$/Ton) Table 47. Global Endocrine Therapy Drugs (ETDs) Price by Type (2027-2032) & (US$/Ton) Table 48. Global Endocrine Therapy Drugs (ETDs) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2021-2026) Table 52. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2027-2032) Table 53. Global Endocrine Therapy Drugs (ETDs) Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 54. Global Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 55. Global Endocrine Therapy Drugs (ETDs) Sales by Application (2027-2032) & (Tons) Table 56. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2021-2026) Table 57. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2027-2032) Table 58. Global Endocrine Therapy Drugs (ETDs) Price by Application (2021-2026) & (US$/Ton) Table 59. Global Endocrine Therapy Drugs (ETDs) Price by Application (2027-2032) & (US$/Ton) Table 60. Sanofi Company Information Table 61. Sanofi Business Overview Table 62. Sanofi Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 63. Sanofi Endocrine Therapy Drugs (ETDs) Product Portfolio Table 64. Sanofi Recent Development Table 65. Pfizer Company Information Table 66. Pfizer Business Overview Table 67. Pfizer Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Pfizer Endocrine Therapy Drugs (ETDs) Product Portfolio Table 69. Pfizer Recent Development Table 70. Bayer Company Information Table 71. Bayer Business Overview Table 72. Bayer Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Bayer Endocrine Therapy Drugs (ETDs) Product Portfolio Table 74. Bayer Recent Development Table 75. AstraZeneca Company Information Table 76. AstraZeneca Business Overview Table 77. AstraZeneca Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. AstraZeneca Endocrine Therapy Drugs (ETDs) Product Portfolio Table 79. AstraZeneca Recent Development Table 80. Tonghua Dongbao Pharmaceutical Company Information Table 81. Tonghua Dongbao Pharmaceutical Business Overview Table 82. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Product Portfolio Table 84. Tonghua Dongbao Pharmaceutical Recent Development Table 85. Novo Nordisk Company Information Table 86. Novo Nordisk Business Overview Table 87. Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Novo Nordisk Endocrine Therapy Drugs (ETDs) Product Portfolio Table 89. Novo Nordisk Recent Development Table 90. MSD Company Information Table 91. MSD Business Overview Table 92. MSD Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. MSD Endocrine Therapy Drugs (ETDs) Product Portfolio Table 94. MSD Recent Development Table 95. Huadong Medicine Company Information Table 96. Huadong Medicine Business Overview Table 97. Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Huadong Medicine Endocrine Therapy Drugs (ETDs) Product Portfolio Table 99. Huadong Medicine Recent Development Table 100. Generex Biotechnology Company Information Table 101. Generex Biotechnology Business Overview Table 102. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Product Portfolio Table 104. Generex Biotechnology Recent Development Table 105. North America Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Endocrine Therapy Drugs (ETDs) Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 108. North America Endocrine Therapy Drugs (ETDs) Sales by Type (2027-2032) & (Tons) Table 109. North America Endocrine Therapy Drugs (ETDs) Sales Price by Type (2021-2026) & (US$/Ton) Table 110. North America Endocrine Therapy Drugs (ETDs) Sales Price by Type (2027-2032) & (US$/Ton) Table 111. North America Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Endocrine Therapy Drugs (ETDs) Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 114. North America Endocrine Therapy Drugs (ETDs) Sales by Application (2027-2032) & (Tons) Table 115. North America Endocrine Therapy Drugs (ETDs) Sales Price by Application (2021-2026) & (US$/Ton) Table 116. North America Endocrine Therapy Drugs (ETDs) Sales Price by Application (2027-2032) & (US$/Ton) Table 117. North America Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. North America Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. North America Endocrine Therapy Drugs (ETDs) Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 121. North America Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 122. North America Endocrine Therapy Drugs (ETDs) Sales by Country (2027-2032) & (Tons) Table 123. North America Endocrine Therapy Drugs (ETDs) Sales Price by Country (2021-2026) & (US$/Ton) Table 124. North America Endocrine Therapy Drugs (ETDs) Sales Price by Country (2027-2032) & (US$/Ton) Table 125. United States Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 126. Canada Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 127. Europe Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Endocrine Therapy Drugs (ETDs) Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 130. Europe Endocrine Therapy Drugs (ETDs) Sales by Type (2027-2032) & (Tons) Table 131. Europe Endocrine Therapy Drugs (ETDs) Sales Price by Type (2021-2026) & (US$/Ton) Table 132. Europe Endocrine Therapy Drugs (ETDs) Sales Price by Type (2027-2032) & (US$/Ton) Table 133. Europe Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Endocrine Therapy Drugs (ETDs) Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 136. Europe Endocrine Therapy Drugs (ETDs) Sales by Application (2027-2032) & (Tons) Table 137. Europe Endocrine Therapy Drugs (ETDs) Sales Price by Application (2021-2026) & (US$/Ton) Table 138. Europe Endocrine Therapy Drugs (ETDs) Sales Price by Application (2027-2032) & (US$/Ton) Table 139. Europe Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Europe Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 143. Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 144. Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2027-2032) & (Tons) Table 145. Europe Endocrine Therapy Drugs (ETDs) Sales Price by Country (2021-2026) & (US$/Ton) Table 146. Europe Endocrine Therapy Drugs (ETDs) Sales Price by Country (2027-2032) & (US$/Ton) Table 147. Germany Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 148. France Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 149. U.K. Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 150. Italy Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 151. Netherlands Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 152. China Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2026) & (US$ Million) Table 153. China Endocrine Therapy Drugs (ETDs) Revenue by Type (2027-2032) & (US$ Million) Table 154. China Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 155. China Endocrine Therapy Drugs (ETDs) Sales by Type (2027-2032) & (Tons) Table 156. China Endocrine Therapy Drugs (ETDs) Sales Price by Type (2021-2026) & (US$/Ton) Table 157. China Endocrine Therapy Drugs (ETDs) Sales Price by Type (2027-2032) & (US$/Ton) Table 158. China Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2026) & (US$ Million) Table 159. China Endocrine Therapy Drugs (ETDs) Revenue by Application (2027-2032) & (US$ Million) Table 160. China Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 161. China Endocrine Therapy Drugs (ETDs) Sales by Application (2027-2032) & (Tons) Table 162. China Endocrine Therapy Drugs (ETDs) Sales Price by Application (2021-2026) & (US$/Ton) Table 163. China Endocrine Therapy Drugs (ETDs) Sales Price by Application (2027-2032) & (US$/Ton) Table 164. Asia Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2026) & (US$ Million) Table 165. Asia Endocrine Therapy Drugs (ETDs) Revenue by Type (2027-2032) & (US$ Million) Table 166. Asia Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 167. Asia Endocrine Therapy Drugs (ETDs) Sales by Type (2027-2032) & (Tons) Table 168. Asia Endocrine Therapy Drugs (ETDs) Sales Price by Type (2021-2026) & (US$/Ton) Table 169. Asia Endocrine Therapy Drugs (ETDs) Sales Price by Type (2027-2032) & (US$/Ton) Table 170. Asia Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2026) & (US$ Million) Table 171. Asia Endocrine Therapy Drugs (ETDs) Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 173. Asia Endocrine Therapy Drugs (ETDs) Sales by Application (2027-2032) & (Tons) Table 174. Asia Endocrine Therapy Drugs (ETDs) Sales Price by Application (2021-2026) & (US$/Ton) Table 175. Asia Endocrine Therapy Drugs (ETDs) Sales Price by Application (2027-2032) & (US$/Ton) Table 176. Asia Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Asia Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Asia Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Asia Endocrine Therapy Drugs (ETDs) Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 180. Asia Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 181. Asia Endocrine Therapy Drugs (ETDs) Sales by Country (2027-2032) & (Tons) Table 182. Asia Endocrine Therapy Drugs (ETDs) Sales Price by Country (2021-2026) & (US$/Ton) Table 183. Asia Endocrine Therapy Drugs (ETDs) Sales Price by Country (2027-2032) & (US$/Ton) Table 184. Japan Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 185. South Korea Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 186. India Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 187. Australia Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 188. China Taiwan Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 189. Southeast Asia Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 190. SAMEA Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2026) & (US$ Million) Table 191. SAMEA Endocrine Therapy Drugs (ETDs) Revenue by Type (2027-2032) & (US$ Million) Table 192. SAMEA Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 193. SAMEA Endocrine Therapy Drugs (ETDs) Sales by Type (2027-2032) & (Tons) Table 194. SAMEA Endocrine Therapy Drugs (ETDs) Sales Price by Type (2021-2026) & (US$/Ton) Table 195. SAMEA Endocrine Therapy Drugs (ETDs) Sales Price by Type (2027-2032) & (US$/Ton) Table 196. SAMEA Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA Endocrine Therapy Drugs (ETDs) Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 199. SAMEA Endocrine Therapy Drugs (ETDs) Sales by Application (2027-2032) & (Tons) Table 200. SAMEA Endocrine Therapy Drugs (ETDs) Sales Price by Application (2021-2026) & (US$/Ton) Table 201. SAMEA Endocrine Therapy Drugs (ETDs) Sales Price by Application (2027-2032) & (US$/Ton) Table 202. SAMEA Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. SAMEA Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. SAMEA Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. SAMEA Endocrine Therapy Drugs (ETDs) Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 206. SAMEA Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 207. SAMEA Endocrine Therapy Drugs (ETDs) Sales by Country (2027-2032) & (Tons) Table 208. SAMEA Endocrine Therapy Drugs (ETDs) Sales Price by Country (2021-2026) & (US$/Ton) Table 209. SAMEA Endocrine Therapy Drugs (ETDs) Sales Price by Country (2027-2032) & (US$/Ton) Table 210. Brazil Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 211. Argentina Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 212. Chile Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 213. Colombia Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 214. Peru Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 215. Saudi Arabia Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 216. Israel Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 217. UAE Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 218. Turkey Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 219. Iran Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 220. Egypt Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Endocrine Therapy Drugs (ETDs) Distributors List Table 224. Endocrine Therapy Drugs (ETDs) Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Endocrine Therapy Drugs (ETDs) Image Figure 2. Global Endocrine Therapy Drugs (ETDs) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endocrine Therapy Drugs (ETDs) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Antidiabetic Drugs Image Figure 5. Anti-osteoporosis Drugs Image Figure 6. Contraceptive Image Figure 7. Other Image Figure 8. Global Endocrine Therapy Drugs (ETDs) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Endocrine Therapy Drugs (ETDs) Market Size Share 2021 VS 2025 VS 2032 Figure 10. Diabetes Treatment Image Figure 11. Osteoporosis Treatment Image Figure 12. Contraception Image Figure 13. Other Image Figure 14. Global Endocrine Therapy Drugs (ETDs) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Figure 16. Global Endocrine Therapy Drugs (ETDs) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2021-2032) Figure 19. Global Endocrine Therapy Drugs (ETDs) Sales (2021-2032) & (Tons) Figure 20. Global Endocrine Therapy Drugs (ETDs) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 21. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Endocrine Therapy Drugs (ETDs) Sales YoY (2021-2032) & (Tons) Figure 23. Europe Endocrine Therapy Drugs (ETDs) Sales YoY (2021-2032) & (Tons) Figure 24. China Endocrine Therapy Drugs (ETDs) Sales YoY (2021-2032) & (Tons) Figure 25. Asia (Excluding China) Endocrine Therapy Drugs (ETDs) Sales YoY (2021-2032) & (Tons) Figure 26. South America, Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales YoY (2021-2032) & (Tons) Figure 27. Global Endocrine Therapy Drugs (ETDs) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Endocrine Therapy Drugs (ETDs) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2021-2032) Figure 33. Global Endocrine Therapy Drugs (ETDs) Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 34. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2021-2032) Figure 36. Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2021-2032) Figure 39. Global Endocrine Therapy Drugs (ETDs) Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 40. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2021-2032) Figure 42. North America Endocrine Therapy Drugs (ETDs) Revenue Share by Type (2021-2032) Figure 43. North America Endocrine Therapy Drugs (ETDs) Sales Share by Type (2021-2032) Figure 44. North America Endocrine Therapy Drugs (ETDs) Revenue Share by Application (2021-2032) Figure 45. North America Endocrine Therapy Drugs (ETDs) Sales Share by Application (2021-2032) Figure 46. North America Endocrine Therapy Drugs (ETDs) Revenue Share by Country (2021-2032) Figure 47. North America Endocrine Therapy Drugs (ETDs) Sales Share by Country (2021-2032) Figure 48. Europe Endocrine Therapy Drugs (ETDs) Revenue Share by Type (2021-2032) Figure 49. Europe Endocrine Therapy Drugs (ETDs) Sales Share by Type (2021-2032) Figure 50. Europe Endocrine Therapy Drugs (ETDs) Revenue Share by Application (2021-2032) Figure 51. Europe Endocrine Therapy Drugs (ETDs) Sales Share by Application (2021-2032) Figure 52. Europe Endocrine Therapy Drugs (ETDs) Revenue Share by Country (2021-2032) Figure 53. Europe Endocrine Therapy Drugs (ETDs) Sales Share by Country (2021-2032) Figure 54. China Endocrine Therapy Drugs (ETDs) Revenue Share by Type (2021-2032) Figure 55. China Endocrine Therapy Drugs (ETDs) Sales Share by Type (2021-2032) Figure 56. China Endocrine Therapy Drugs (ETDs) Revenue Share by Application (2021-2032) Figure 57. China Endocrine Therapy Drugs (ETDs) Sales Share by Application (2021-2032) Figure 58. Asia Endocrine Therapy Drugs (ETDs) Revenue Share by Type (2021-2032) Figure 59. Asia Endocrine Therapy Drugs (ETDs) Sales Share by Type (2021-2032) Figure 60. Asia Endocrine Therapy Drugs (ETDs) Revenue Share by Application (2021-2032) Figure 61. Asia Endocrine Therapy Drugs (ETDs) Sales Share by Application (2021-2032) Figure 62. Asia Endocrine Therapy Drugs (ETDs) Revenue Share by Country (2021-2032) Figure 63. Asia Endocrine Therapy Drugs (ETDs) Sales Share by Country (2021-2032) Figure 64. SAMEA Endocrine Therapy Drugs (ETDs) Revenue Share by Type (2021-2032) Figure 65. SAMEA Endocrine Therapy Drugs (ETDs) Sales Share by Type (2021-2032) Figure 66. SAMEA Endocrine Therapy Drugs (ETDs) Revenue Share by Application (2021-2032) Figure 67. SAMEA Endocrine Therapy Drugs (ETDs) Sales Share by Application (2021-2032) Figure 68. SAMEA Endocrine Therapy Drugs (ETDs) Revenue Share by Country (2021-2032) Figure 69. SAMEA Endocrine Therapy Drugs (ETDs) Sales Share by Country (2021-2032) Figure 70. Endocrine Therapy Drugs (ETDs) Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Endocrine Therapy Drugs (ETDs) Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Antidiabetic Drugs
  • Anti-osteoporosis Drugs
  • Contraceptive
  • Other
Applications
  • Diabetes Treatment
  • Osteoporosis Treatment
  • Contraception
  • Other
Companies covered
  • Sanofi
  • Pfizer
  • Bayer
  • AstraZeneca
  • Tonghua Dongbao Pharmaceutical
  • Novo Nordisk
  • MSD
  • Huadong Medicine
  • Generex Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Endocrine Therapy Drugs (ETDs) Market by Type
  3. 1.2.1 Global Endocrine Therapy Drugs (ETDs) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Antidiabetic Drugs
  5. 1.2.3 Anti-osteoporosis Drugs
  6. 1.2.4 Contraceptive
  7. 1.2.5 Other
  8. 1.3 Endocrine Therapy Drugs (ETDs) Market by Application
  9. 1.3.1 Global Endocrine Therapy Drugs (ETDs) Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Diabetes Treatment
  11. 1.3.3 Osteoporosis Treatment
  12. 1.3.4 Contraception
  13. 1.3.5 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Endocrine Therapy Drugs (ETDs) Market Dynamics
  1. 2.1 Endocrine Therapy Drugs (ETDs) Industry Trends
  2. 2.2 Endocrine Therapy Drugs (ETDs) Industry Drivers
  3. 2.3 Endocrine Therapy Drugs (ETDs) Industry Opportunities and Challenges
  4. 2.4 Endocrine Therapy Drugs (ETDs) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Endocrine Therapy Drugs (ETDs) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Region
  3. 3.2.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Region (2021-2026)
  5. 3.2.3 Global Endocrine Therapy Drugs (ETDs) Revenue by Region (2027-2032)
  6. 3.2.4 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Endocrine Therapy Drugs (ETDs) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Endocrine Therapy Drugs (ETDs) Sales by Region
  9. 3.4.1 Global Endocrine Therapy Drugs (ETDs) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Endocrine Therapy Drugs (ETDs) Sales by Region (2021-2026)
  11. 3.4.3 Global Endocrine Therapy Drugs (ETDs) Sales by Region (2027-2032)
  12. 3.4.4 Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Manufacturers
  2. 4.1.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Endocrine Therapy Drugs (ETDs) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Endocrine Therapy Drugs (ETDs) Sales by Manufacturers
  6. 4.2.1 Global Endocrine Therapy Drugs (ETDs) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Endocrine Therapy Drugs (ETDs) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Endocrine Therapy Drugs (ETDs) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Endocrine Therapy Drugs (ETDs) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Endocrine Therapy Drugs (ETDs) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Endocrine Therapy Drugs (ETDs) Manufacturers, Product Type & Application
  13. 4.7 Global Endocrine Therapy Drugs (ETDs) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Endocrine Therapy Drugs (ETDs) Market CR5 and HHI
  16. 4.8.2 2025 Endocrine Therapy Drugs (ETDs) Tier 1, Tier 2, and Tier 3
5 Endocrine Therapy Drugs (ETDs) Market by Type
  1. 5.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Type
  2. 5.1.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Endocrine Therapy Drugs (ETDs) Sales by Type
  6. 5.2.1 Global Endocrine Therapy Drugs (ETDs) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Endocrine Therapy Drugs (ETDs) Price by Type
6 Endocrine Therapy Drugs (ETDs) Market by Application
  1. 6.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Application
  2. 6.1.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Endocrine Therapy Drugs (ETDs) Sales by Application
  6. 6.2.1 Global Endocrine Therapy Drugs (ETDs) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Endocrine Therapy Drugs (ETDs) Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Endocrine Therapy Drugs (ETDs) Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Endocrine Therapy Drugs (ETDs) Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 Bayer
  14. 7.3.1 Bayer Company Information
  15. 7.3.2 Bayer Business Overview
  16. 7.3.3 Bayer Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bayer Endocrine Therapy Drugs (ETDs) Product Portfolio
  18. 7.3.5 Bayer Recent Developments
  19. 7.4 AstraZeneca
  20. 7.4.1 AstraZeneca Company Information
  21. 7.4.2 AstraZeneca Business Overview
  22. 7.4.3 AstraZeneca Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca Endocrine Therapy Drugs (ETDs) Product Portfolio
  24. 7.4.5 AstraZeneca Recent Developments
  25. 7.5 Tonghua Dongbao Pharmaceutical
  26. 7.5.1 Tonghua Dongbao Pharmaceutical Company Information
  27. 7.5.2 Tonghua Dongbao Pharmaceutical Business Overview
  28. 7.5.3 Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Product Portfolio
  30. 7.5.5 Tonghua Dongbao Pharmaceutical Recent Developments
  31. 7.6 Novo Nordisk
  32. 7.6.1 Novo Nordisk Company Information
  33. 7.6.2 Novo Nordisk Business Overview
  34. 7.6.3 Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Novo Nordisk Endocrine Therapy Drugs (ETDs) Product Portfolio
  36. 7.6.5 Novo Nordisk Recent Developments
  37. 7.7 MSD
  38. 7.7.1 MSD Company Information
  39. 7.7.2 MSD Business Overview
  40. 7.7.3 MSD Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 MSD Endocrine Therapy Drugs (ETDs) Product Portfolio
  42. 7.7.5 MSD Recent Developments
  43. 7.8 Huadong Medicine
  44. 7.8.1 Huadong Medicine Company Information
  45. 7.8.2 Huadong Medicine Business Overview
  46. 7.8.3 Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Huadong Medicine Endocrine Therapy Drugs (ETDs) Product Portfolio
  48. 7.8.5 Huadong Medicine Recent Developments
  49. 7.9 Generex Biotechnology
  50. 7.9.1 Generex Biotechnology Company Information
  51. 7.9.2 Generex Biotechnology Business Overview
  52. 7.9.3 Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Generex Biotechnology Endocrine Therapy Drugs (ETDs) Product Portfolio
  54. 7.9.5 Generex Biotechnology Recent Developments
8 North America
  1. 8.1 North America Endocrine Therapy Drugs (ETDs) Market Size by Type
  2. 8.1.1 North America Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2032)
  3. 8.1.2 North America Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2032)
  4. 8.1.3 North America Endocrine Therapy Drugs (ETDs) Price by Type (2021-2032)
  5. 8.2 North America Endocrine Therapy Drugs (ETDs) Market Size by Application
  6. 8.2.1 North America Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2032)
  7. 8.2.2 North America Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2032)
  8. 8.2.3 North America Endocrine Therapy Drugs (ETDs) Price by Application (2021-2032)
  9. 8.3 North America Endocrine Therapy Drugs (ETDs) Market Size by Country
  10. 8.3.1 North America Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Endocrine Therapy Drugs (ETDs) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Endocrine Therapy Drugs (ETDs) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Endocrine Therapy Drugs (ETDs) Market Size by Type
  2. 9.1.1 Europe Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2032)
  4. 9.1.3 Europe Endocrine Therapy Drugs (ETDs) Price by Type (2021-2032)
  5. 9.2 Europe Endocrine Therapy Drugs (ETDs) Market Size by Application
  6. 9.2.1 Europe Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2032)
  8. 9.2.3 Europe Endocrine Therapy Drugs (ETDs) Price by Application (2021-2032)
  9. 9.3 Europe Endocrine Therapy Drugs (ETDs) Market Size by Country
  10. 9.3.1 Europe Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Endocrine Therapy Drugs (ETDs) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Endocrine Therapy Drugs (ETDs) Market Size by Type
  2. 10.1.1 China Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2032)
  3. 10.1.2 China Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2032)
  4. 10.1.3 China Endocrine Therapy Drugs (ETDs) Price by Type (2021-2032)
  5. 10.2 China Endocrine Therapy Drugs (ETDs) Market Size by Application
  6. 10.2.1 China Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2032)
  7. 10.2.2 China Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2032)
  8. 10.2.3 China Endocrine Therapy Drugs (ETDs) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Endocrine Therapy Drugs (ETDs) Market Size by Type
  2. 11.1.1 Asia Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2032)
  4. 11.1.3 Asia Endocrine Therapy Drugs (ETDs) Price by Type (2021-2032)
  5. 11.2 Asia Endocrine Therapy Drugs (ETDs) Market Size by Application
  6. 11.2.1 Asia Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2032)
  8. 11.2.3 Asia Endocrine Therapy Drugs (ETDs) Price by Application (2021-2032)
  9. 11.3 Asia Endocrine Therapy Drugs (ETDs) Market Size by Country
  10. 11.3.1 Asia Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Endocrine Therapy Drugs (ETDs) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Endocrine Therapy Drugs (ETDs) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Endocrine Therapy Drugs (ETDs) Market Size by Type
  2. 12.1.1 SAMEA Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Endocrine Therapy Drugs (ETDs) Price by Type (2021-2032)
  5. 12.2 SAMEA Endocrine Therapy Drugs (ETDs) Market Size by Application
  6. 12.2.1 SAMEA Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Endocrine Therapy Drugs (ETDs) Price by Application (2021-2032)
  9. 12.3 SAMEA Endocrine Therapy Drugs (ETDs) Market Size by Country
  10. 12.3.1 SAMEA Endocrine Therapy Drugs (ETDs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Endocrine Therapy Drugs (ETDs) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Endocrine Therapy Drugs (ETDs) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Endocrine Therapy Drugs (ETDs) Value Chain Analysis
  2. 13.1.1 Endocrine Therapy Drugs (ETDs) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Endocrine Therapy Drugs (ETDs) Production Mode & Process
  6. 13.2 Endocrine Therapy Drugs (ETDs) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Endocrine Therapy Drugs (ETDs) Distributors
  9. 13.2.3 Endocrine Therapy Drugs (ETDs) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst